Cytosorbents Corp — Director's Dealing 2017

Jun 13, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cytosorbents Corp (CTSO)
CIK: 0001175151
Period of Report: 2017-06-09

Reporting Person: BATOR MICHAEL G. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-06-09	Common Stock	P	1500	$4.12	Acquired	70500	Direct

Footnotes

F1: Includes (i) the following restricted stock units ("RSUs") that will be settled into common stock upon vesting upon a "Change In Control" of CytoSorbents Corporation, as defined in the CytoSorbents Corporation 2014 Long-Term Incentive Plan: (a) 6,000 RSUs granted on February 24, 2017 and (b) 60,000 RSUs granted on June 7, 2016 and (ii) 4,500 shares of common stock owned by the reporting person (including 1,500 shares of common stock purchased in the open market on June 9, 2017 and reported on this Form 4).